Cancer is a disease of aging and, as the world's population ages, the number of older
persons with cancer is increasing and will make up a growing share of the oncology …

Breast cancer is increasingly prevalent in older adults and is a substantial part of routine
oncology practice. However, management of breast cancer in this population is challenging …

Importance Although geriatric assessment–driven intervention improves patient-centered
outcomes, its influence on chemotherapy-related toxic effects remains unknown. Objective …

PURPOSE: For patients with cancer who are older than 65 years, the 2018 ASCO Guideline
recommends geriatric assessment (GA) be performed. However, there are limited data on …

As the majority of patients with cancer are older than 65 years, most medical, surgical, and
radiation oncologists treat a large number of older adults in their clinical practice. Older …

PURPOSE Limited tools exist to predict the risk of chemotherapy toxicity in older adults with
early-stage breast cancer. METHODS Patients of age≥ 65 years with stage I-III breast …

Significant progress has been made toward improving the care of older adults with cancer.
As described elsewhere in this Special Series, the evidence base in geriatric oncology has …

Purpose Polypharmacy is prevalent in older adults starting cancer treatment and associated
with potentially inappropriate medications (PIM), potential drug-drug interactions (DDI), and …

Despite substantial improvements in the outcomes of patients with cancer over the past two
decades, older adults (aged≥ 65 years) with cancer are a rapidly increasing population and …

Background Older patients with colorectal cancer (CRC) experience chemotherapy dose
reductions or discontinuation. Comprehensive geriatric assessment (CGA) predicts survival …